Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

Recent Press Releases

May 21, 2013 - 4:31 p.m.
European Medicines Agency Validates Gilead’s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
Printer Friendly Version 
May 17, 2013 - 4:06 p.m.
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
Printer Friendly Version 
May 15, 2013 - 6:31 p.m.
Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia
Printer Friendly Version 

Upcoming Events

Wednesday, May 29, 2013 10:00 a.m. through Friday, May 31, 2013 ET
38th Annual Deutsche Bank Healthcare Conference
Friday, May 31, 2013 through Tuesday, June 4, 2013
American Society of Clinical Oncology Annual 2013 Meeting
Thursday, June 6, 2013 through Monday, June 10, 2013
Asian Pacific Association for the Study of the Liver – Liver Week
Tuesday, June 11, 2013 through Thursday, June 13, 2013
34th Annual Goldman Sachs Healthcare Conference
Wednesday, June 12, 2013 through Saturday, June 15, 2013
36th European Cystic Fibrosis Society Conference
Thursday, June 13, 2013 through Sunday, June 16, 2013
18th Congress of European Hematology Association
Tuesday, June 18, 2013 through Wednesday, June 19, 2013
Wells Fargo Securities Research & Economics 2013 Healthcare Conference

Most Viewed Links

Updated 05/25/13
1.Stock Information
2.SEC Filings
3.Stock Quote
4.Annual Reports
5.Fundamentals - Snapshot
* Data collected 05/17/13 - 05/24/13

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
$55.81
 Stock is Up 0.33 (0.59%)
Data as of 05/24/13 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Webcast Replay
Gilead Sciences at UBS Global Healthcare Conference

May 20, 2013 9:30 a.m. ET
Play
First Quarter 2013 Gilead Sciences Earnings Conference Call

May 02, 2013 4:30 p.m. ET
Play
  • 2012 Annual Report  
  • 2012 Form 10-K  
  • Financial Tear Sheet  
Get help downloading or viewing the above file types